Astera Labs (ALAB) stock has surged 146.4% in the past three months, outperforming the Computer & Technology sector and Internet – Software industry. Revenue growth is driven by strong demand for Aries, Taurus, and Scorpio product lines. Scorpio P-Series switches are the fastest-growing product line, accounting for over 10% of total revenues.

ALAB is expanding its portfolio to meet the demand for AI infrastructure solutions, ramping production of PCIe 6 connectivity products. Partnering with chipmakers like NVIDIA, ALAB is enhancing its offerings to optimize data center performance. Aries 6 PCIe solution supports PCIe 6 and began volume ramping in 2025.

ALAB expects strong growth in Q3 2025, with revenue projected between $203 million and $210 million, and earnings between 38 cents and 39 cents per share. Estimates show an 82.80% increase in revenue and a 69.57% increase in earnings year-over-year for Q3 2025.

Despite strong performance, ALAB faces competition from Marvell Technology and Broadcom in the PCIe retimers market. ALAB’s stock is trading at a premium, with a Value Score of F and a Price/Sales ratio of 38.90X, higher than the sector average of 6.94X.

Astera Labs’ innovative portfolio and partnerships drive growth, but macroeconomic challenges and competition pose risks. With a Zacks Rank #3 (Hold), waiting for a better entry point may be wise. Stiff competition and stretched valuation remain concerns.

Read more at Nasdaq: ALAB Rises 146% in Three Months: Should You Buy the Stock Now or Wait?